To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene UBASH3BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
305 supporting clones for gene UBASH3B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA722908   .a 1 to 428 2 to 429   tiling clone, capped   428/428
(100 %)
0 diff
(100 %id)
NM_032873.4   .a 15 to 6916 1 to 6902 exact RefSeq, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 6902/6902
(100 %)
0 diff
(100 %id)
DA197468 brain .a 16 to 588 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA241613 brain .a 16 to 545 2 to 531   capped   530/537
(98 %)
6 diff
(98.9 %id)
DA655844   .a 33 to 545 2 to 516   capped   515/570
(90 %)
8 diff
(98.6 %id)
DB246643   .a 33 to 545 2 to 513   capped   512/817
(62 %)
9 diff
(98.9 %id)
CB137980 Liver .a 43 to 513 1 to 471       471/471
(100 %)
3 diff
(99.4 %id)
CB139400 Liver .a 43 to 411 1 to 369       369/369
(100 %)
5 diff
(98.7 %id)
DA099589 cerebellum .a 44 to 545 2 to 504   capped   503/548
(91 %)
7 diff
(98.8 %id)
DA320421 hippocampus .a 44 to 545 2 to 503   capped   502/542
(92 %)
7 diff
(98.8 %id)
BP363901 lung .a 45 to 545 1 to 501       501/582
(86 %)
8 diff
(98.7 %id)
DA100283 cerebellum .a 46 to 545 2 to 501   capped   500/553
(90 %)
6 diff
(99.0 %id)
DA914296   .a 46 to 545 2 to 501   capped   500/549
(91 %)
7 diff
(98.8 %id)
DB284441 uterus .a 46 to 545 2 to 501   capped   500/511
(97 %)
8 diff
(98.5 %id)
AK075203 placenta .a 47 to 2346 1 to 2300 exact available from FLJ,   2300/2300
(100 %)
2 diff
(100.0 %id)
BP200360 amygdala .a 47 to 545 1 to 499       499/583
(85 %)
6 diff
(99.0 %id)
BP222215   .a 47 to 545 1 to 499       499/582
(85 %)
7 diff
(98.8 %id)
BP222577   .a 47 to 545 1 to 499       499/582
(85 %)
7 diff
(98.8 %id)
BP222666   .a 47 to 545 1 to 499       499/582
(85 %)
7 diff
(98.8 %id)
DB442750 testis .a 47 to 218 1 to 173       173/173
(100 %)
6 diff
(96.6 %id)
BP234237 coronary artery .a 47 to 535 1 to 489       489/583
(83 %)
3 diff
(99.5 %id)
BP234612 coronary artery .a 47 to 545 1 to 499       499/583
(85 %)
8 diff
(98.7 %id)
BP236546 coronary artery .a 47 to 592 1 to 546       546/581
(93 %)
0 diff
(100 %id)
BP241366 Liver .a 47 to 554 1 to 509       509/558
(91 %)
24 diff
(95.7 %id)
BP278890   .a 47 to 545 1 to 499       499/583
(85 %)
10 diff
(98.3 %id)
BP279030   .a 47 to 545 1 to 501       501/583
(85 %)
18 diff
(97.0 %id)
BP285085 lung .a 47 to 545 1 to 499       499/581
(85 %)
16 diff
(97.3 %id)
BP286055 lung .a 47 to 545 1 to 499       499/583
(85 %)
7 diff
(98.8 %id)
DA803418 brain .a 47 to 433 2 to 389   capped   388/388
(100 %)
1 diff
(99.8 %id)
DA859266 placenta .a 47 to 574 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
BP365583 lung .a 47 to 545 1 to 499       499/583
(85 %)
8 diff
(98.7 %id)
BP365991 lung .a 47 to 545 1 to 499       499/581
(85 %)
8 diff
(98.7 %id)
DA018908   .a 48 to 545 2 to 500   capped   499/528
(94 %)
7 diff
(98.7 %id)
DA023913   .a 48 to 545 2 to 499   capped   498/570
(87 %)
7 diff
(98.8 %id)
DA026613   .a 48 to 545 2 to 499   capped   498/584
(85 %)
7 diff
(98.9 %id)
DA027099   .a 48 to 545 2 to 500   capped   499/560
(89 %)
7 diff
(98.8 %id)
DA029527   .a 48 to 592 2 to 546   capped   545/564
(96 %)
0 diff
(100 %id)
DA029917   .a 48 to 592 2 to 546   capped   545/555
(98 %)
0 diff
(100 %id)
DA032491   .a 48 to 592 2 to 546   capped   545/576
(94 %)
0 diff
(100 %id)
DA101909 cerebellum .a 48 to 592 2 to 546   capped   545/552
(98 %)
2 diff
(99.7 %id)
DA109046 cerebellum .a 48 to 592 2 to 546   capped   545/584
(93 %)
2 diff
(99.7 %id)
DA109628 cerebellum .a 48 to 545 2 to 500   capped   499/538
(92 %)
7 diff
(98.7 %id)
DA122343 cerebellum .a 48 to 525 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
DA164829 amygdala .a 48 to 520 2 to 474   capped   473/473
(100 %)
1 diff
(99.8 %id)
DA238087 brain .a 48 to 592 2 to 546   capped   545/576
(94 %)
0 diff
(100 %id)
DA265032 caudate nucleus .a 48 to 545 2 to 499   capped   498/505
(98 %)
6 diff
(98.9 %id)
DA343469 substantia nigra .a 48 to 545 2 to 499   capped   498/574
(86 %)
8 diff
(98.7 %id)
DA400779 thalamus .a 48 to 545 2 to 499   capped   498/505
(98 %)
6 diff
(98.9 %id)
BP223804 colon mucosa .a 48 to 539 1 to 492       492/599
(82 %)
4 diff
(99.4 %id)
DA475560   .a 48 to 545 2 to 499   capped   498/560
(88 %)
8 diff
(98.6 %id)
DA481822   .a 48 to 592 2 to 546   capped   545/550
(99 %)
0 diff
(100 %id)
DA482615   .a 48 to 592 2 to 546   capped   545/577
(94 %)
0 diff
(100 %id)
DA514795 brain .a 48 to 525 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
DA648384   .a 48 to 592 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA649263   .a 48 to 535 2 to 489   capped   488/545
(89 %)
1 diff
(99.9 %id)
DA649425   .a 48 to 592 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DA650308   .a 48 to 581 2 to 535   capped   534/534
(100 %)
2 diff
(99.7 %id)
DA653346   .a 48 to 592 2 to 546   capped   545/588
(92 %)
2 diff
(99.7 %id)
DA653635   .a 48 to 583 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA657157   .a 48 to 592 2 to 546   capped   545/579
(94 %)
2 diff
(99.7 %id)
DA658002   .a 48 to 592 2 to 546   capped   545/573
(95 %)
0 diff
(100 %id)
DA659068   .a 48 to 592 2 to 546   capped   545/565
(96 %)
0 diff
(100 %id)
DA660893   .a 48 to 545 2 to 501   capped   500/558
(89 %)
8 diff
(98.6 %id)
DA661235   .a 48 to 592 2 to 546   capped   545/555
(98 %)
0 diff
(100 %id)
DA661389   .a 48 to 545 2 to 499   capped   498/558
(89 %)
7 diff
(98.8 %id)
DA672107   .a 48 to 592 2 to 546   capped   545/590
(92 %)
0 diff
(100 %id)
DA716483   .a 48 to 545 2 to 506   capped   505/577
(87 %)
13 diff
(97.8 %id)
DA735778   .a 48 to 545 2 to 499   capped   498/661
(75 %)
6 diff
(99.1 %id)
DA814578   .a 48 to 525 2 to 479   capped   478/478
(100 %)
1 diff
(99.8 %id)
DA832416 placenta .a 48 to 766 2 to 719   capped   718/719
(99 %)
16 diff
(97.8 %id)
DA835963 placenta .a 48 to 525 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
DA854679 placenta .a 48 to 545 2 to 500   capped   499/582
(85 %)
8 diff
(98.7 %id)
DA854991 placenta .a 48 to 545 2 to 500   capped   499/595
(83 %)
7 diff
(98.9 %id)
DA857944 placenta .a 48 to 545 2 to 499   capped   498/544
(91 %)
7 diff
(98.8 %id)
DA883569   .a 48 to 545 2 to 499   capped   498/505
(98 %)
6 diff
(98.9 %id)
DA935289 Spleen .a 48 to 545 2 to 499   capped   498/590
(84 %)
8 diff
(98.7 %id)
DA948117 Spleen .a 48 to 545 2 to 499   capped   498/556
(89 %)
8 diff
(98.6 %id)
DA948128 Spleen .a 48 to 545 2 to 501   capped   500/529
(94 %)
10 diff
(98.2 %id)
DA996113 synovial membrane tissue from rheumatioidarthritis .a 48 to 545 2 to 499   capped   498/560
(88 %)
7 diff
(98.8 %id)
DB030288 testis .a 48 to 545 2 to 499   capped   498/592
(84 %)
8 diff
(98.7 %id)
DB072757 testis .a 48 to 501 2 to 455   capped   454/454
(100 %)
0 diff
(100 %id)
DB074373 testis .a 48 to 545 2 to 501   capped   500/504
(99 %)
11 diff
(97.9 %id)
DB088424 testis .a 48 to 545 2 to 499   capped   498/558
(89 %)
9 diff
(98.4 %id)
DB100517 testis .a 48 to 545 2 to 499   capped   498/600
(83 %)
8 diff
(98.7 %id)
DB106223 thymus .a 48 to 545 2 to 499   capped   498/538
(92 %)
10 diff
(98.2 %id)
DB137628 thymus .a 48 to 545 2 to 499   capped   498/527
(94 %)
7 diff
(98.7 %id)
DB149340 thymus .a 48 to 545 2 to 500   capped   499/512
(97 %)
7 diff
(98.7 %id)
DA649089   .a 51 to 545 2 to 496   capped   495/561
(88 %)
8 diff
(98.6 %id)
DA480104   .a 52 to 415 2 to 365   capped   364/364
(100 %)
2 diff
(99.5 %id)
DA554237   .a 52 to 545 2 to 495   capped   494/547
(90 %)
8 diff
(98.6 %id)
DA659336   .a 52 to 592 2 to 542   capped   541/588
(92 %)
0 diff
(100 %id)
DA799223 brain .a 52 to 545 2 to 496   capped   495/523
(94 %)
7 diff
(98.7 %id)
DA399485 thalamus .a 53 to 545 2 to 494   capped   493/522
(94 %)
7 diff
(98.7 %id)
DA863800 placenta .a 55 to 592 2 to 539   capped   538/572
(94 %)
0 diff
(100 %id)
BG422509 Kidney, renal cell adenocarcinoma .a 58 to 727 1 to 667       667/667
(100 %)
14 diff
(98.0 %id)
BC007541 Kidney, renal cell adenocarcinoma .a 61 to 3601 1 to 3542 exact available from MGC, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 3542/3542
(100 %)
1 diff
(100.0 %id)
AW732295 Kidney, renal cell adenocarcinoma .a 62 to 592 1 to 531       531/571
(92 %)
2 diff
(99.7 %id)
AK222843 Liver .a 65 to 2342 1 to 2278 A68T H465R AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 2278/2278
(100 %)
6 diff
(99.8 %id)
AK222846 Liver .a 65 to 2342 1 to 2278 A68T H465R AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 2278/2278
(100 %)
6 diff
(99.8 %id)
BP240340 Liver .a 65 to 545 1 to 482       482/564
(85 %)
14 diff
(97.6 %id)
BP240343 Liver .a 65 to 545 1 to 481       481/560
(85 %)
13 diff
(97.7 %id)
BP353276   .a 68 to 545 1 to 478       478/582
(82 %)
10 diff
(98.3 %id)
BG340279 leiomyosarcoma cell line, uterus .a 73 to 539 1 to 468       468/958
(48 %)
13 diff
(98.7 %id)
BQ933850 epidermoid carcinoma, cell line, lung .a 91 to 545 1 to 455       455/833
(54 %)
6 diff
(99.3 %id)
BQ925639 epidermoid carcinoma, cell line, lung .a 91 to 932 1 to 847       847/851
(99 %)
12 diff
(98.6 %id)
BP363458 lung .a 105 to 686 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CN366764 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 127 to 365 1 to 239       239/239
(100 %)
2 diff
(99.2 %id)
AB075839 brain .a 163 to 4883 1 to 4722 exact tiling clone, available from KIAA,   4722/4722
(100 %)
3 diff
(100.0 %id)
BG335883 choriocarcinoma, placenta .a 180 to 539 1 to 358       358/912
(39 %)
14 diff
(98.5 %id)
BX509679   .a 194 to 545 1 to 354       354/421
(84 %)
9 diff
(97.9 %id)
DN992376 brain, whole brain .a 203 to 900 32 to 729       698/729
(95 %)
6 diff
(99.2 %id)
BM454467 embryonal carcinoma, cell line, testis .a 216 to 1101 1 to 895       897/960
(93 %)
15 diff
(98.5 %id)
AA243100 brain, neuroepithelial cells .a 219 to 545 1 to 323       323/407
(79 %)
10 diff
(97.6 %id)
DB145170 thymus .a 240 to 592 2 to 354   capped   353/416
(84 %)
2 diff
(99.6 %id)
BU191886 embryonal carcinoma, cell line, testis .a 268 to 976 1 to 717       717/942
(76 %)
9 diff
(99.1 %id)
CR749088 embryonal carcinoma, cell line, testis .a 292 to 802 1 to 511       511/511
(100 %)
6 diff
(98.9 %id)
BQ434192 embryonal carcinoma, cell line, testis .a 304 to 777 1 to 474       474/1019
(46 %)
9 diff
(99.2 %id)
DA580085   .a 313 to 881 2 to 570   capped   569/569
(100 %)
6 diff
(99.0 %id)
BP246766 Kidney .a 345 to 919 1 to 576       576/580
(99 %)
9 diff
(98.5 %id)
TI_1948240892   .a 374 to 1448 125 to 1197   AAA   1073/1268
(84 %)
41 diff
(96.8 %id)
TI_1948240893   .a 374 to 1463 125 to 1201       1077/1285
(83 %)
53 diff
(95.9 %id)
EL733324 mixed .a 375 to 1019 1 to 645       645/645
(100 %)
0 diff
(100 %id)
CN366766 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 536 to 908 95 to 466       372/466
(79 %)
9 diff
(98.1 %id)
BX441364 brain, fetal brain .a 536 to 1133 1 to 602       602/615
(97 %)
24 diff
(96.1 %id)
BG387576 embryonal carcinoma, cell line, testis .a 536 to 934 309 to 707       399/990
(40 %)
17 diff
(98.3 %id)
TI_1948240601   .a 536 to 975 274 to 717       444/1402
(31 %)
31 diff
(97.8 %id)
CB116118 Liver .a 558 to 910 1 to 353       353/353
(100 %)
3 diff
(99.2 %id)
BQ421700 embryonal carcinoma, cell line, testis .a 708 to 1354 41 to 693       653/988
(66 %)
29 diff
(97.1 %id)
AF425252   .a 718 to 3604 1 to 2886   tiling clone,   2886/2889
(99 %)
4 diff
(99.9 %id)
BQ213814 embryonal carcinoma, cell line, testis .a 722 to 1231 1 to 516       516/1142
(45 %)
11 diff
(99.1 %id)
DB143159 thymus .a 777 to 1247 60 to 530   capped   471/529
(89 %)
10 diff
(98.2 %id)
BM803529 leiomyosarcoma, uterus .a 916 to 1554 104 to 749       646/1393
(46 %)
28 diff
(98.0 %id)
BG391102 embryonal carcinoma, cell line, testis .a 962 to 1449 1 to 488       488/490
(99 %)
1 diff
(99.8 %id)
BX409800 brain, fetal brain .a 1060 to 1931 1 to 882       882/927
(95 %)
38 diff
(96.0 %id)
BX409801 brain, fetal brain .a 1063 to 1969 1 to 906       906/906
(100 %)
7 diff
(99.3 %id)
EH313047   .a 1074 to 1131 1 to 58       58/58
(100 %)
2 diff
(96.6 %id)
BP363132 lung .a 1074 to 1661 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
BM468048 melanotic melanoma, skin .a 1216 to 2080 32 to 903       872/1071
(81 %)
16 diff
(98.6 %id)
DB447551 testis .a 1237 to 1671 1 to 434       434/434
(100 %)
8 diff
(98.2 %id)
TI_1948240894   .a 1348 to 2329 1102 to 121       982/1278
(76 %)
21 diff
(98.4 %id)
BU196772 ductal carcinoma, cell line, Pancreas .a 1388 to 2185 1 to 800       800/867
(92 %)
14 diff
(98.4 %id)
AA039281 uterus .a 1407 to 1609 1 to 204       204/237
(86 %)
3 diff
(98.8 %id)
AA047189 uterus .a 1407 to 1567 16 to 176       161/176
(91 %)
10 diff
(94.4 %id)
BG391982 embryonal carcinoma, cell line, testis .a 1449 to 2191 1 to 744       744/988
(75 %)
19 diff
(98.1 %id)
TI_1948240895   .a 1485 to 2329 953 to 115       839/1398
(60 %)
40 diff
(97.2 %id)
BU509577 leiomyosarcoma, uterus .a 1542 to 2341 1 to 808       808/910
(88 %)
12 diff
(98.7 %id)
W23818 senescent fibroblast .a 1665 to 2000 1 to 343   fully sequenced,   343/343
(100 %)
6 diff
(98.3 %id)
BX117211 senescent fibroblast .a 1667 to 2333 1 to 669       669/669
(100 %)
3 diff
(99.6 %id)
BG392397 embryonal carcinoma, cell line, testis .a 1674 to 2493 1 to 824       824/902
(91 %)
31 diff
(96.6 %id)
TI_1948240340   .a 1688 to 2329 1236 to 597     Submitted on the opposite strand 565/1293
(43 %)
23 diff
(98.3 %id)
BM542343 melanotic melanoma, skin .a 1710 to 2644 1 to 948   AAA   948/989
(95 %)
27 diff
(97.3 %id)
AA037664 uterus .a 1787 to 2346 559 to 1       561/559
(100 %)
10 diff
(98.3 %id)
DB368125   .a 1789 to 2342 557 to 1       557/557
(100 %)
14 diff
(97.5 %id)
CN366765 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1809 to 2382 1 to 574       574/574
(100 %)
0 diff
(100 %id)
TI_1948240339   .a 1822 to 2329 1092 to 587     Submitted on the opposite strand 506/1224
(41 %)
24 diff
(98.1 %id)
TI_1948241173   .a 1822 to 2329 1100 to 593     Submitted on the opposite strand 508/1274
(39 %)
11 diff
(99.2 %id)
TI_1948241172   .a 1832 to 2329 1091 to 598     Submitted on the opposite strand 494/1246
(39 %)
19 diff
(98.5 %id)
AI129677 uterus .a 1860 to 2346 486 to 1       486/486
(100 %)
1 diff
(99.8 %id)
AA628006 colon, colon tumor RER+ .a 1900 to 2339 440 to 1       440/440
(100 %)
0 diff
(100 %id)
CN366763 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1934 to 2663 1 to 731       731/731
(100 %)
2 diff
(99.8 %id)
N94611 senescent fibroblast .a 1939 to 2342 406 to 1   fully sequenced,   406/406
(100 %)
3 diff
(99.3 %id)
AA047190 uterus .a 1943 to 2346 410 to 1       410/410
(100 %)
8 diff
(98.1 %id)
DB378598 placenta .a 1965 to 2346 383 to 1       383/503
(76 %)
10 diff
(98.1 %id)
CB158284 Liver .a 1966 to 2211 246 to 1     Submitted on the opposite strand 246/246
(100 %)
0 diff
(100 %id)
BQ067194 pooled brain, lung, testis .a 2020 to 3062 24 to 1079       1056/1138
(92 %)
29 diff
(97.5 %id)
DA353216 substantia nigra .a 2049 to 2593 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA353502 substantia nigra .a 2049 to 2603 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
AW080715 esophagus, squamous cell carcinoma .a 2063 to 2342 318 to 39   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 280/315
(88 %)
27 diff
(91.5 %id)
BE551736 pooled germ cell tumors .a 2065 to 2343 279 to 1       279/279
(100 %)
3 diff
(99.0 %id)
AW403791 lymph .a 2134 to 2629 1 to 496     Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 496/496
(100 %)
10 diff
(98.0 %id)
TI_154140584   .a 2139 to 2841 79 to 783       705/708
(99 %)
30 diff
(95.8 %id)
DA102217 cerebellum .a 2166 to 2755 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
BX497335 Liver .a 2199 to 2645 1 to 446       446/446
(100 %)
3 diff
(99.4 %id)
AA323744 brain, cerebellum .a 2223 to 2483 1 to 261       261/261
(100 %)
0 diff
(100 %id)
AW960956   .a 2224 to 2596 1 to 372       372/444
(83 %)
30 diff
(93.3 %id)
BM802606 embryonal carcinoma, cell line, testis .a 2231 to 3311 1 to 1083       1083/1110
(97 %)
44 diff
(96.1 %id)
BG169163 hypernephroma, cell line, Kidney .a 2275 to 2737 1 to 469       469/1036
(45 %)
12 diff
(98.9 %id)
BQ216272 melanotic melanoma, skin .a 2285 to 2789 1 to 510       510/1258
(40 %)
24 diff
(98.1 %id)
CB136499 Liver .a 2311 to 2896 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
DA860428 placenta .a 2328 to 2895 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AA043510 uterus .a 2436 to 2628 1 to 193       193/193
(100 %)
1 diff
(99.5 %id)
BF701301 brain, primitive neuroectoderm .a 2496 to 3028 1 to 535       535/817
(65 %)
22 diff
(97.4 %id)
AL833092 Spinal cord .a 2506 to 6910 1 to 4407   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 4407/4407
(100 %)
9 diff
(99.8 %id)
DA816386   .a 2625 to 3197 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BU942683 mixed (pool of 40 RNAs) .a 2643 to 3395 1 to 754       754/759
(99 %)
14 diff
(98.2 %id)
AI207358 placenta .a 2751 to 3122 1 to 372     Submitted on the opposite strand 372/372
(100 %)
1 diff
(99.8 %id)
AA464845   .a 2756 to 3264 1 to 509     Submitted on the opposite strand 509/509
(100 %)
0 diff
(100 %id)
BU620007 Cell Line, Chondrosarcoma .a 2826 to 3601 792 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 774/774
(100 %)
7 diff
(99.1 %id)
CA307610 Alveolar Macrophage, lung .a 2857 to 3601 763 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 745/745
(100 %)
2 diff
(99.8 %id)
BI054531 placenta_normal .a 2887 to 3333 8 to 453       446/453
(98 %)
6 diff
(98.7 %id)
BU619553 Cell Line, Chondrosarcoma .a 2933 to 3601 686 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 668/668
(100 %)
1 diff
(99.9 %id)
BU627084 Bone, Enchondroma cell line .a 2934 to 3601 686 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 668/668
(100 %)
0 diff
(100 %id)
TI_154132331   .a 2938 to 3601 759 to 97   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 663/665
(99 %)
6 diff
(99.1 %id)
BQ311022 breast_normal .a 2958 to 3335 78 to 464       387/469
(82 %)
18 diff
(96.2 %id)
CA423611 cell lines, Chondrosarcoma .a 2962 to 3601 659 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 641/641
(100 %)
1 diff
(99.9 %id)
CA307587 Alveolar Macrophage, lung .a 2968 to 3601 652 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 634/634
(100 %)
4 diff
(99.4 %id)
DA095791 cerebellum .a 2994 to 3563 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BF667010 brain, primitive neuroectoderm .a 3024 to 3600 1 to 576   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 576/576
(100 %)
5 diff
(99.2 %id)
AW574891 lymph .a 3030 to 3601 589 to 18   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 572/572
(100 %)
0 diff
(100 %id)
DB283741 uterus .a 3076 to 3627 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
AI291779 placenta .a 3156 to 3604 455 to 7       449/455
(98 %)
0 diff
(100 %id)
BG113948 Bone, osteosarcoma, cell line .a 3156 to 3865 1 to 705       705/705
(100 %)
10 diff
(98.6 %id)
AA232138 brain, neuroepithelial cells .a 3181 to 3601 421 to 1       421/421
(100 %)
1 diff
(99.8 %id)
BG391641 embryonal carcinoma, cell line, testis .a 3201 to 3938 1 to 728       728/956
(76 %)
21 diff
(97.9 %id)
DA911845   .a 3231 to 3773 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA419837 cord Blood .a 3256 to 3814 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BQ948760 leiomyosarcoma, uterus .a 3322 to 3924 1 to 608       608/1117
(54 %)
24 diff
(97.9 %id)
BX498200 Liver .a 3324 to 3719 1 to 397       397/397
(100 %)
5 diff
(98.8 %id)
BE714209 head_neck .a 3357 to 3523 1 to 169       169/169
(100 %)
3 diff
(98.3 %id)
BE714361 head_neck .a 3358 to 3523 1 to 163       163/163
(100 %)
4 diff
(97.6 %id)
AA043511 uterus .a 3367 to 3601 239 to 1       239/333
(71 %)
4 diff
(98.8 %id)
DA092029 cerebellum .a 3377 to 3922 2 to 547   capped   546/550
(99 %)
2 diff
(99.7 %id)
DA235010 brain .a 3390 to 3974 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
DA102513 cerebellum .a 3479 to 4074 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
DA118031 cerebellum .a 3546 to 4083 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
AK092011   .a 3562 to 5723 1 to 2162   tiling clone, available from FLJ,   2162/2162
(100 %)
2 diff
(100.0 %id)
DA648401   .a 3563 to 4115 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
BF696101 brain, primitive neuroectoderm .a 3598 to 4242 1 to 646       646/838
(77 %)
26 diff
(96.9 %id)
BM469511 embryonal carcinoma, cell line, testis .a 3605 to 4557 34 to 996       963/1048
(91 %)
42 diff
(96.0 %id)
CB119738 Liver .a 3610 to 4080 1 to 470       470/470
(100 %)
2 diff
(99.6 %id)
BG615849 embryonal carcinoma, testis .a 3770 to 4480 1 to 714       714/715
(99 %)
15 diff
(98.0 %id)
AI093453 uterus .a 3822 to 4270 459 to 11   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 449/449
(100 %)
2 diff
(99.6 %id)
DB507644 testis .a 3866 to 4266 1 to 400     Submitted on the opposite strand 400/400
(100 %)
9 diff
(97.8 %id)
BG503747 embryonal carcinoma, testis .a 3958 to 4647 1 to 706       706/707
(99 %)
35 diff
(95.1 %id)
BU601308 mixed (pool of 40 RNAs) .a 3999 to 4819 1 to 832       832/837
(99 %)
26 diff
(96.9 %id)
AA932758 pooled germ cell tumors .a 4003 to 4268 270 to 4       267/270
(98 %)
0 diff
(100 %id)
AA932759 pooled germ cell tumors .a 4003 to 4268 269 to 4       266/269
(98 %)
0 diff
(100 %id)
AA233308 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4030 to 4477 1 to 448       448/448
(100 %)
4 diff
(99.2 %id)
AI654413 pooled germ cell tumors .a 4082 to 4259 199 to 22   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 178/178
(100 %)
0 diff
(100 %id)
BU169816 embryonal carcinoma, cell line, testis .a 4146 to 4919 1 to 779       779/852
(91 %)
11 diff
(98.8 %id)
BG696863 skin .a 4166 to 4895 1 to 730       730/730
(100 %)
0 diff
(100 %id)
BM464793 lymph, lymphoma, cell line .a 4183 to 5263 1 to 1092       1092/1103
(99 %)
29 diff
(97.4 %id)
BQ227419 embryonal carcinoma, cell line, testis .a 4185 to 4824 1 to 641   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 641/641
(100 %)
1 diff
(99.9 %id)
DA652676   .a 4328 to 4867 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
BF131257 hypernephroma, Kidney .a 4355 to 4966 1 to 620       620/842
(73 %)
12 diff
(98.6 %id)
CB120563 Liver .a 4393 to 4577 1 to 185       185/185
(100 %)
2 diff
(99.0 %id)
BF700194 brain, primitive neuroectoderm .a 4435 to 5041 1 to 607       607/865
(70 %)
13 diff
(98.5 %id)
BQ438859 embryonal carcinoma, cell line, testis .a 4535 to 5406 1 to 872       872/877
(99 %)
18 diff
(98.0 %id)
BG113096 Bone, osteosarcoma, cell line .a 4609 to 5234 1 to 624   AAA   624/786
(79 %)
22 diff
(97.3 %id)
BG113942 Bone, osteosarcoma, cell line .a 4610 to 5327 1 to 721       721/869
(82 %)
26 diff
(97.1 %id)
CB105408 Liver .a 4638 to 5306 1 to 669       669/669
(100 %)
3 diff
(99.6 %id)
BG391400 embryonal carcinoma, cell line, testis .a 4796 to 5528 1 to 731       731/967
(75 %)
18 diff
(98.2 %id)
AA471284   .a 4805 to 5301 1 to 481       481/481
(100 %)
25 diff
(94.9 %id)
BM996244 lung, Metastatic Chondrosarcoma .a 4861 to 5568 723 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 705/705
(100 %)
3 diff
(99.6 %id)
TI_149308113   .a 4903 to 5725 935 to 117       819/1049
(78 %)
0 diff
(100 %id)
CA440069 lung, Metastatic Chondrosarcoma .a 4923 to 5558 653 to 18       636/653
(97 %)
0 diff
(100 %id)
DB327683   .a 4960 to 5536 579 to 1       579/579
(100 %)
4 diff
(99.4 %id)
BG614707 embryonal carcinoma, testis .a 4964 to 5531 1 to 568       568/568
(100 %)
8 diff
(98.6 %id)
BE048602 Kidney .a 5013 to 5535 529 to 7       523/529
(98 %)
0 diff
(100 %id)
BE221865 Kidney .a 5029 to 5549 521 to 1       521/521
(100 %)
1 diff
(99.9 %id)
BU686989 lung, Primary Lung Epithelial Cells .a 5052 to 5725 690 to 17       674/690
(97 %)
0 diff
(100 %id)
AI927919 Kidney .a 5116 to 5569 464 to 12       453/464
(97 %)
0 diff
(100 %id)
BU186503 embryonal carcinoma, cell line, testis .a 5132 to 5873 1 to 753       753/965
(78 %)
24 diff
(97.6 %id)
AA937164 pooled .a 5137 to 5541 405 to 1       405/405
(100 %)
1 diff
(99.8 %id)
AA233309 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 5139 to 5536 398 to 1       398/398
(100 %)
2 diff
(99.5 %id)
DB321620   .a 5201 to 5723 523 to 1       523/523
(100 %)
0 diff
(100 %id)
AL121292 melanoma (MeWo cell line) .a 5502 to 5863 13 to 374       362/362
(100 %)
0 diff
(100 %id)
BG620032 placenta .a 5517 to 6307 1 to 788       788/817
(96 %)
24 diff
(97.1 %id)
BG505507 embryonal carcinoma, testis .a 5597 to 6320 1 to 718       718/720
(99 %)
19 diff
(97.4 %id)
BG614203 embryonal carcinoma, testis .a 5700 to 6386 1 to 692       692/805
(85 %)
17 diff
(97.9 %id)
BG006781 placenta_normal .a 5834 to 6378 30 to 573       544/587
(92 %)
11 diff
(98.2 %id)
CB121572 Liver .a 5859 to 6404 1 to 546       546/546
(100 %)
2 diff
(99.7 %id)
BF540940 hypernephroma, Kidney .a 6065 to 6672 1 to 606       606/764
(79 %)
31 diff
(96.0 %id)
BG504834 embryonal carcinoma, testis .a 6107 to 6851 9 to 750       742/799
(92 %)
12 diff
(98.5 %id)
CB121071 Liver .a 6119 to 6554 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
W31170 senescent fibroblast .a 6150 to 6643 1 to 511       511/533
(95 %)
23 diff
(95.7 %id)
CA313832 Human Lung Epithelial cells, lung .a 6184 to 6910 745 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 727/727
(100 %)
1 diff
(99.9 %id)
BF508750   .a 6250 to 6909 677 to 18   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 660/660
(100 %)
1 diff
(99.9 %id)
BE463830 pooled germ cell tumors .a 6359 to 6909 552 to 2       551/552
(99 %)
0 diff
(100 %id)
AA040446 uterus .a 6364 to 6652 1 to 289   fully sequenced,   289/289
(100 %)
1 diff
(99.7 %id)
DB321738   .a 6364 to 6909 547 to 1       547/548
(99 %)
1 diff
(99.9 %id)
BX097412 uterus .a 6366 to 6916 1 to 553   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 553/553
(100 %)
2 diff
(99.7 %id)
CR741636 uterus .a 6366 to 6916 1 to 551   tiling clone, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 551/551
(100 %)
0 diff
(100 %id)
AI418293 brain, glioblastoma (pooled) .a 6469 to 6909 467 to 27   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 441/441
(100 %)
5 diff
(98.9 %id)
AW769786 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 6549 to 6911 363 to 1       363/363
(100 %)
1 diff
(99.8 %id)
G36808   .a 6583 to 6909 334 to 8     Submitted on the opposite strand 327/336
(97 %)
0 diff
(100 %id)
AA040447 uterus .a 6622 to 6916 295 to 1   fully sequenced,   295/295
(100 %)
0 diff
(100 %id)
BM983666 lung, Primary Lung Epithelial Cells .a 6661 to 6910 267 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 249/282
(88 %)
4 diff
(98.6 %id)
CA311198 Human Lung Epithelial cells, lung .a 6661 to 6910 267 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 249/283
(87 %)
3 diff
(99.0 %id)
N98732 senescent fibroblast .a 6804 to 6909 112 to 8       105/116
(90 %)
0 diff
(100 %id)
DA943964 Spleen .b-u 1 to 559 9 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
DB122359 thymus .b-u 1 to 533 7 to 539   tiling clone, capped   538/538
(100 %)
2 diff
(99.7 %id)
BQ709207 Spleen .b-u 305 to 923 1 to 621   tiling clone,   621/982
(63 %)
21 diff
(97.9 %id)
BG745602 Spleen .b-u 309 to 1004 1 to 692   tiling clone,   692/692
(100 %)
23 diff
(96.7 %id)
TI_57198287   .c 1 to 742 66 to 813 P23R L24C L26W E27S L28S ... tiling clone,   748/814
(91 %)
19 diff
(97.7 %id)
BI819894 pooled brain, lung, testis .c 2 to 699 1 to 702   tiling clone,   702/748
(93 %)
13 diff
(98.3 %id)
DA584629 lung .c 70 to 617 2 to 549   tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
BP291729 lung .c 77 to 657 1 to 582   tiling clone,   582/582
(100 %)
38 diff
(93.5 %id)
CB137430 Liver .d 1 to 547 1 to 547   tiling clone,   547/547
(100 %)
1 diff
(99.9 %id)
DA031196   .d 6 to 572 2 to 568 R12S P46S tiling clone, capped   567/567
(100 %)
2 diff
(99.7 %id)
DA121613 cerebellum .d 6 to 520 2 to 516   capped   515/515
(100 %)
0 diff
(100 %id)
TI_1948240602   .e 1 to 530 333 to 865 S4V Y5T R6G L7Y F8S ... tiling clone,   533/1433
(37 %)
33 diff
(97.7 %id)
BE926664 breast .f 1 to 537 5 to 540 L6S E8R T9R T10L P11L ... tiling clone,   536/540
(99 %)
6 diff
(98.9 %id)
BQ304008 breast .f 199 to 691 499 to 2   tiling clone,   498/499
(99 %)
0 diff
(100 %id)
DA657999   .g 1 to 567 6 to 572 exact tiling clone, capped   571/571
(100 %)
0 diff
(100 %id)
AI924043 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h 1 to 419 447 to 29 exact tiling clone, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 419/419
(100 %)
1 diff
(99.8 %id)
BF057704 pooled germ cell tumors .h 155 to 422 284 to 17 L32F AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 268/274
(97 %)
5 diff
(98.2 %id)
BM462624 leiomyosarcoma, uterus .h 155 to 266 44 to 154 exact     570/1140
(50 %)
18 diff
(98.5 %id)
CF529157 placenta .h 155 to 422 282 to 15 exact tiling clone, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 268/278
(96 %)
2 diff
(99.3 %id)
AI350838 pooled germ cell tumors .h 162 to 429 270 to 3 exact tiling clone,   268/270
(99 %)
0 diff
(100 %id)
AI337059 pooled germ cell tumors .h 164 to 429 268 to 3 exact     266/268
(99 %)
0 diff
(100 %id)
BF222993 pooled germ cell tumors .h 164 to 429 269 to 3 L32F     267/269
(99 %)
1 diff
(99.7 %id)
DA844562 placenta .i 1 to 557 2 to 558   tiling clone, capped   557/557
(100 %)
5 diff
(99.2 %id)
DA407859 thalamus .j 1 to 549 2 to 551   tiling clone, capped   550/550
(100 %)
2 diff
(99.7 %id)
AW813909 stomach Gene UBASH3B, variant not shown         This clone was ignored    
DA093912 cerebellum Gene UBASH3B, variant not shown       capped This clone was ignored    
DW443387 Liver Gene UBASH3B, variant not shown              
DA481108   Gene UBASH3B, variant not shown       capped This clone was ignored    
BI494263 cochlea, ear Gene UBASH3B, variant not shown       fully sequenced, Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base)    
BI494264 cochlea, ear Gene UBASH3B, variant not shown       fully sequenced, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base)    
BI493999 cochlea, ear Gene UBASH3B, variant not shown       fully sequenced, Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base)    
BI494000 cochlea, ear Gene UBASH3B, variant not shown       fully sequenced, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base)    
BF243215 bone marrow, from acute myelogenous leukemia Gene UBASH3B, variant not shown         Suspected internal deletion, this clone was ignored    
BI767065 pooled lung and spleen Gene UBASH3B, variant not shown              
BQ708953 Spleen Gene UBASH3B, variant not shown       AAA      
DB361864 mammary gland Gene UBASH3B, variant not shown         This clone was ignored    
DA647049 mammary gland Gene UBASH3B, variant not shown       capped This clone was ignored    
DB378778 placenta Gene UBASH3B, variant not shown         Suspected internal deletion, this clone was ignored    
DA832538 placenta Gene UBASH3B, variant not shown       capped Suspected internal deletion, this clone was ignored    
DA885935   Gene UBASH3B, variant not shown       capped This clone was ignored    
DB093641 testis Gene UBASH3B, variant not shown       capped This clone was ignored    
DB123485 thymus Gene UBASH3B, variant not shown       capped      
DB344117 thymus Gene UBASH3B, variant not shown              
DB136595 thymus Gene UBASH3B, variant not shown       capped      
DB345048 thymus Gene UBASH3B, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b-u, .c, .d, .e, .f, .g, .h, .i, .j Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI